{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:45:17Z","timestamp":1759365917262,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["12755"],"award-info":[{"award-number":["12755"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.humimm.2020.02.010","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T08:13:18Z","timestamp":1582704798000},"page":"218-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study"],"prefix":"10.1016","volume":"81","author":[{"given":"Armina Alagheband","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Bandehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahram","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Bozorgmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariman","family":"Mosaffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouzbeh","family":"Chegeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2020.02.010_b0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/13543776.2012.673589","article-title":"Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities","volume":"22","author":"Roohvand","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"issue":"42","key":"10.1016\/j.humimm.2020.02.010_b0015","doi-asserted-by":"crossref","first-page":"11984","DOI":"10.3748\/wjg.v21.i42.11984","article-title":"Progress in the development of vaccines for hepatitis C virus infection","volume":"21","author":"Ghasemi","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.humimm.2020.02.010_b0020","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1517\/13543776.2011.630662","article-title":"Advances in hepatitis C virus vaccines, Part one: advances in basic knowledge for hepatitis C virus vaccine design","volume":"21","author":"Roohvand","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.humimm.2020.02.010_b0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cellimm.2009.11.005","article-title":"Fusion of HBsAg and prime\/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine","volume":"261","author":"Memarnejadian","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.humimm.2020.02.010_b0030","first-page":"1021","article-title":"RecombinanthepatitisB vaccine (Engerix\u2014B) A review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"KeatingGM","year":"2003","journal-title":"Drugs"},{"issue":"suppl_1","key":"10.1016\/j.humimm.2020.02.010_b0035","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"suppl_1","key":"10.1016\/j.humimm.2020.02.010_b0040","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"43","key":"10.1016\/j.humimm.2020.02.010_b0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.15585\/mmwr.mm6643a6","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2016\u2013June 2017","volume":"66","author":"Jorba","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"1","key":"10.1016\/j.humimm.2020.02.010_b0050","first-page":"13","article-title":"The virology of the polio virus","volume":"3","author":"Adu","year":"2005","journal-title":"Ann. Ibadan Postgraduate Med."},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3103\/S0891416817040097","article-title":"In silico prediction and in vitro verification of a novel multi-epitope antigen for HBV detection","volume":"32","author":"Khalili","year":"2017","journal-title":"Mol Genetics, Microbiol. Virol."},{"issue":"6","key":"10.1016\/j.humimm.2020.02.010_b0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08830185.2019.1657426","article-title":"Immunoinformatics: in silico approaches and computational design of a multi-epitope, immunogenic protein","volume":"38","author":"Alagheband Bahrami","year":"2019","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0065","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10989-018-9797-3","article-title":"In silico analysis for determination and validation of iron-regulated protein from Escherichia coli","volume":"25","author":"Sefid","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.humimm.2020.02.010_b0070","first-page":"1","article-title":"Computational design and analysis of a poly-epitope fusion protein: a new vaccine candidate for hepatitis and poliovirus","author":"Alagheband Bahrami","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.humimm.2020.02.010_b0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.imlet.2018.11.008","article-title":"Designing a diagnostic kit for Oxalyl CoA decarboxylase enzyme by ELISA method","volume":"205","author":"Abarghooi-Kahaki","year":"2019","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0080","first-page":"239","article-title":"Using recombinant chlamydia major outer membrane protein (MOMP) in ELISA diagnostic Kit","volume":"4","author":"Bandehpour","year":"2006","journal-title":"Iran. J. Biotechnol."},{"key":"10.1016\/j.humimm.2020.02.010_b0085","doi-asserted-by":"crossref","unstructured":"Lan K, Verma SC, Murakami M, Bajaj B, Robertson ES. Isolation of human peripheral blood mononuclear cells (PBMCs). Curr. Protocols Microbiol., 2017;6(1):A. 4C. 1-A. 4C. 9.","DOI":"10.1002\/9780471729259.mca04cs6"},{"issue":"2","key":"10.1016\/j.humimm.2020.02.010_b0090","first-page":"173","article-title":"Cloning and expression of hepatitis C virus core protein in pGemex-1 expression vector","volume":"11","author":"Kazemi","year":"2008","journal-title":"Archives of Iranian medicine."},{"issue":"1","key":"10.1016\/j.humimm.2020.02.010_b0095","first-page":"17","article-title":"Cloning and expression of Hepatitis B surface antigen","volume":"8","author":"Bandehpour","year":"2008","journal-title":"Hepatitis Monthly."},{"issue":"3","key":"10.1016\/j.humimm.2020.02.010_b0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.192.3.405","article-title":"Human monocyte\u2013derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1\/Th2 effectors: role of stimulator\/responder ratio","volume":"192","author":"Tanaka","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2020.02.010_b0105","article-title":"The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation","author":"Quah","year":"201044","journal-title":"Journal of visualized experiments: JoVE."},{"issue":"9","key":"10.1016\/j.humimm.2020.02.010_b0110","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.humimm.2020.02.010_b0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/CVI.00490-09","article-title":"The wild-type hepatitis C virus core inhibits initiation of antigen-specific T-and B-cell immune responses in BALB\/c mice","volume":"17","author":"Zhu","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.humimm.2020.02.010_b0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/2277-9175.148296","article-title":"Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB\/c mice","volume":"4","author":"Yazdanian","year":"2015","journal-title":"Advanced biomedical research."},{"issue":"7","key":"10.1016\/j.humimm.2020.02.010_b0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/092986609788681788","article-title":"Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB\/c mice","volume":"16","author":"Memarnejadian","year":"2009","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.humimm.2020.02.010_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11262-009-0417-3","article-title":"Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB\/c mice","volume":"40","author":"Arashkia","year":"2010","journal-title":"Virus Genes"},{"issue":"12","key":"10.1016\/j.humimm.2020.02.010_b0135","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1128\/jvi.64.12.6090-6100.1990","article-title":"Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles","volume":"64","author":"Delpeyroux","year":"1990","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.humimm.2020.02.010_b0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9071(199610)50:2<145::AID-JMV7>3.0.CO;2-A","article-title":"Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles","volume":"50","author":"Lee","year":"1996","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.humimm.2020.02.010_b0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc2373","article-title":"Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines","volume":"8","author":"Melief","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.humimm.2020.02.010_b0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/DDDT.S67861","article-title":"Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach","volume":"8","author":"Oany","year":"2014","journal-title":"Drug Design Develop. Therapy"},{"issue":"3","key":"10.1016\/j.humimm.2020.02.010_b0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08830185.2012.680552","article-title":"Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development","volume":"31","author":"Alvarez-Lajonchere","year":"2012","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2020.02.010_b0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Multiple roles for CD4+ T cells in anti-tumor immune responses","volume":"222","author":"Kennedy","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2020.02.010_b0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.23.021704.115825","article-title":"Cooperation between CD4+ and CD8+ T cells: when, where, and how","volume":"24","author":"Castellino","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2020.02.010_b0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/13880209.2015.1048371","article-title":"Co-expression of hepatitis C virus polytope\u2013HBsAg and p19-silencing suppressor protein in tobacco leaves","volume":"54","author":"Mohammadzadeh","year":"2016","journal-title":"Pharm. Biol."},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.smim.2005.05.013","article-title":"Monocyte-derived dendritic cells","volume":"17","author":"Le\u00f3n","year":"2005","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2020.02.010_b0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhep.2004.09.014","article-title":"Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors","volume":"42","author":"Piccioli","year":"2005","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.humimm.2020.02.010_b0185","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbrc.2005.05.171","article-title":"A cell line model for the differentiation of human dendritic cells","volume":"333","author":"Berges","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.humimm.2020.02.010_b0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2893.2008.01003.x","article-title":"Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors","volume":"15","author":"Jones","year":"2008","journal-title":"J. Viral Hepatitis"},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2010.05.007","article-title":"A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals","volume":"53","author":"Gowans","year":"2010","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.humimm.2020.02.010_b0200","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2020.02.010_b0205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1753425917714854","article-title":"Decrease of CD69 levels on TCR V\u03b17. 2+ CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients","volume":"23","author":"Yong","year":"2017","journal-title":"Innate Immunity"},{"issue":"4","key":"10.1016\/j.humimm.2020.02.010_b0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201747150","article-title":"The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses","volume":"48","author":"Oleszycka","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2020.02.010_b0215","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.vaccine.2003.08.026","article-title":"Th-1\/Th-2 type cytokine profiles of pig T-cells cultured with antigen-treated monocyte-derived dendritic cells","volume":"22","author":"Raymond","year":"2004","journal-title":"Vaccine"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:52:34Z","timestamp":1759319554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919313370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0198885919313370"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.02.010","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}